BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wiznia LE, Laird ME, Franks AG Jr. Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era. J Eur Acad Dermatol Venereol. 2017;31:1260-1270. [PMID: 28252812 DOI: 10.1111/jdv.14186] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 El Kassas M, Hegazy OM, Salah EM. Effect of treating chronic hepatitis C with direct-acting antivirals on extrahepatic cutaneous manifestations. World J Hepatol 2020; 12(10): 841-849 [PMID: 33200021 DOI: 10.4254/wjh.v12.i10.841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Nihei T, Kiniwa Y, Mikoshiba Y, Joshita S, Okuyama R. Improvement of porphyria cutanea tarda following treatment of hepatitis C virus by direct‐acting antivirals: A case report. J Dermatol 2018;46:e149-51. [DOI: 10.1111/1346-8138.14716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Takata K, Shakado S, Sakamoto K, Fukuda H, Yamauchi R, Fukuda S, Kunimoto H, Umeda K, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Irie M, Sakisaka S. Disappearance of multiple hyperechoic liver nodules in sporadic porphyria cutanea tarda after treatment with ledipasvir/sofosbuvir for hepatitis C. Clin J Gastroenterol 2017;10:459-63. [PMID: 28884440 DOI: 10.1007/s12328-017-0772-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
4 Barajas L, Steuer M, Amerson E. Variable clinical course of lichen planus following hepatitis C cure with direct-acting antivirals: A case series and literature review. J Am Acad Dermatol 2021;84:1142-6. [PMID: 32649959 DOI: 10.1016/j.jaad.2020.05.159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Souza MCC, Martins PHT, Vivian A, Luzzatto L. Diffuse normolipemic plane xanthoma and hepatitis C: chance? An Bras Dermatol 2020;95:261-2. [PMID: 32146013 DOI: 10.1016/j.abd.2019.08.026] [Reference Citation Analysis]
6 Satta R, Pes G, Quarta Colosso B, Dore M. Skin manifestations in patients with hepatitis C virus-related chronic liver disease. J Eur Acad Dermatol Venereol 2018;32:e305-6. [DOI: 10.1111/jdv.14848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Steuer M, Maher A, Amerson E. Three cases of incident lichen planus after direct-acting antiviral treatment for hepatitis C. JAAD Case Rep 2018;4:1068-71. [PMID: 30533471 DOI: 10.1016/j.jdcr.2018.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Khairnar V, Duhan V, Patil AM, Zhou F, Bhat H, Thoens C, Sharma P, Adomati T, Friendrich SK, Bezgovsek J, Dreesen JD, Wennemuth G, Westendorf AM, Zelinskyy G, Dittmer U, Hardt C, Timm J, Göthert JR, Lang PA, Singer BB, Lang KS. CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. Nat Commun 2018;9:2561. [PMID: 29967450 DOI: 10.1038/s41467-018-04832-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
9 Moffat GT, Ren Z, Simone AA. An 18-Month History of Dorsal Foot Lesions. JAMA 2021;325:579-80. [PMID: 33449068 DOI: 10.1001/jama.2020.16053] [Reference Citation Analysis]
10 Kolkhir P, Pereverzina N, Olisova O, Maurer M. Comorbidity of viral hepatitis and chronic spontaneous urticaria: A systematic review. Allergy 2018;73:1946-53. [PMID: 29786879 DOI: 10.1111/all.13482] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Bernardes Filho F, de Oliveira Alves A. Elderly Man With Bullous Eruption on the Feet. Ann Emerg Med 2017;70:598-604. [PMID: 28946983 DOI: 10.1016/j.annemergmed.2017.04.028] [Reference Citation Analysis]
12 To-Figueras J. Association between hepatitis C virus and porphyria cutanea tarda. Mol Genet Metab 2019;128:282-7. [PMID: 31097365 DOI: 10.1016/j.ymgme.2019.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
13 Mester A, Lucaciu O, Ciobanu L, Apostu D, Ilea A, Campian RS. Clinical features and management of oral lichen planus (OLP) with emphasis on the management of hepatitis C virus (HCV)-related OLP. Bosn J Basic Med Sci 2018;18:217-23. [PMID: 29984679 DOI: 10.17305/bjbms.2018.3133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Tawfik YM, Hassany SM, Badran AY, El-Gazzar AF, Alemam MF, Sayed DS. Hepatitis C virus associated skin manifestations in upper Egypt: Before and after direct acting antiviral treatment. Dermatol Ther 2020;33:e14365. [PMID: 33001546 DOI: 10.1111/dth.14365] [Reference Citation Analysis]
15 Polo ML, Laufer N. Extrahepatic manifestations of HCV: the role of direct acting antivirals. Expert Rev Anti Infect Ther. 2017;15:737-746. [PMID: 28696154 DOI: 10.1080/14787210.2017.1354697] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
16 Żychowska M, Żychowska M. No evidence for association between cutaneous lichen planus and hepatitis B and C virus infection in south Poland - a case-control study. Int J Dermatol 2020;59:698-703. [PMID: 32307713 DOI: 10.1111/ijd.14880] [Reference Citation Analysis]
17 Cozzani E, Herzum A, Burlando M, Parodi A. Cutaneous manifestations of HAV, HBV, HCV. Ital J Dermatol Venerol 2021;156:5-12. [PMID: 31804053 DOI: 10.23736/S2784-8671.19.06488-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]